SCHEMBL17525691

SCHEMBL17525691

O=C1CCCC(=O)N1CCc1c[nH]c2ccc(I)cc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 3/20 0.49
▸ RAB9A P51151 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ SLC6A2 P23975 2/20 0.45
▸ SLC6A3 Q01959 2/20 0.45
▸ MPO P05164 3/20 0.45
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ HTR1D P28221 5/20 0.43
▸ HTR1B P28222 5/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ HTR1A P08908 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17525726 0.85 GAA (0.66) SLC6A4RAB9ASMN1; SMN2GAAMAPT
SCHEMBL17525734 0.85 MPO (0.64) SLC6A4MPOKMT2AHTR2AHTR1A
SCHEMBL6948769 0.81 HTR2A (0.67) RAB9ASMN1; SMN2MAPTMEN1KMT2A
SCHEMBL2825796 0.81 RAB9A (0.70) RAB9ASMN1; SMN2GAAMPOMAPT
SCHEMBL11283499 0.79 GAA (0.69) SLC6A4GAAMAPTMEN1KMT2A
SCHEMBL26508375 0.79 MPO (0.67) SLC6A4MPOHTR1DHTR1BHTR2A
SCHEMBL2823989 0.76 TRPM8 (0.62) SLC6A4MAPTMEN1KMT2AHTR1D
SCHEMBL733677 0.75 RAB9A (0.69) RAB9ASMN1; SMN2GAAMPOMAPT
SCHEMBL27502150 0.71 SLC6A4 (0.61) SLC6A4SLC6A2SLC6A3MPOMAPT
SCHEMBL8396474 0.71 HTR1D (0.66) SLC6A4MPOMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2985282-A1 GLUTARIMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING GLUTARIMIDE DERIVATIVES Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) 2016-02-17 — — EP disclosed
Send feedback